AVITENE MICROFIBRILLAR COLLAGEN HEMOSTAT
FDA premarket approval P800002/S014 · decided 2004-10-29
Approval details
- PMA number
- P800002
- Supplement
- S014
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- AVITENE MICROFIBRILLAR COLLAGEN HEMOSTAT
- Generic name
- Agent, absorbable hemostatic, collagen based
- Applicant
- C.R. Bard, Inc.
- Date received
- 2004-10-04
- Decision date
- 2004-10-29
- Days to decision
- 25 days
- Decision code
- OK30
- Product code
- LMF
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Woburn, MA
- Statement
- ELIMINATION AND MODIFICATION OF THE ENDOTOXIN TESTING AND MODIFICATION OF THE LIT SEAL STRENGTH TESTING AND MODIFICATION OF THE FOIL POUCH SEAL STRENGTH TESTING.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.